A Company Analysis of Daiichi Pharmaceutical Co Ltd Including Information on Their Deals Made and Partnering Companies Over a Five Year Period
Posted on: Tuesday, 1 November 2005, 12:00 CST
Research and Markets (http://www.researchandmarkets.com/reports/c26623 ) has announced the addition of Daiichi Pharmaceutical Co Ltd Deals Briefing to their offering
Description
Daiichi Pharmaceutical Co Ltd Deals briefing provides an in-depth view of the 33 deals made by Daiichi Pharmaceutical Co Ltd and its subsidiaries with 37 partnering companies between 2000 and 2005, in a clear and accessible PDF format.
Chapter 1: Company profile
-- An overview of the company, including contact details, a summary of business and partnering interests, and a review of management
Chapter 2: Financial data and deals overview
-- A summary of the company's financial status and overview of the numbers of deals by deal type, therapy focus, deal stage and industry sector.
Chapter 3: Summary of deals
-- A comprehensive overview listing deals by partner company, therapy focus and development stage, with a full index of all the deals announced.
Chapter 4: List of deals
-- A detailed listing of all the company's deals and alliances announced between January 2000 and July 2005.
Every deal is fully categorized, includes a detailed description, and includes financials such as headline value, upfront payments and royalty rates, where disclosed.
Scope
The report contains:
-- a brief company profile including subsidiary names
-- financial information where disclosed
-- a deals overview
-- specialized indexes including deals by partner company, subsidiary company, therapy focus and development stage
-- a detailed listing of the company's deals and alliances.
Key questions answered
-- Daiichi Pharmaceutical Co Ltd Deals briefing provides a comprehensive summary of the deals and alliances announced by the company and its subsidiaries between January 2000 and July 2005. This report helps in:
-- identifying active partners
-- tracking competitor activity
-- benchmarking deals
-- comparing the finances of different deal types.
Daiichi Pharmaceutical Co Ltd Deals briefing brings all relevant partnering deals into one place, providing a reference to deal making by Daiichi Pharmaceutical Co Ltd.
Forecasts, projections, market estimates
This report provides: a financial summary table detailing the yearly total revenues, pharma revenues, R&D spend and profit of the company; and a series of tables detailing the number of deals made by deal type, by therapy focus, by development stage and by industry sector.
Who should buy this report
This report is essential reading for board and executive management, and individuals in:
-- business development
-- licensing/partnering
-- deal making
-- business strategy
-- marketing and promotion
-- distribution and manufacturing (including contract services).
Topics Covered
-- Introduction
-- About Partneringdesk Deals briefings
-- Chapter 1: Company profile
-- Chapter 2: Financial data and deals overview
-- Chapter 3: Summary of deals
-- Deals involving Daiichi Pharmaceutical Co Ltd by partner company
-- Deals involving Daiichi Pharmaceutical Co Ltd by subsidiary
-- Deals involving Daiichi Pharmaceutical Co Ltd by therapy focus
-- Deals involving Daiichi Pharmaceutical Co Ltd by development stage
-- Chapter 4: List of deals
-- Glossary
-- List of Tables
Companies Mentioned
Daiichi Fine Chemical Co Ltd, Daiichi Pharmatech Co Ltd, Daiichi Pure Chemicals Co Ltd, Daiichi Radioisotopes Laboratories Ltd, Daiichi Sankyo Company Ltd, Daiichi Suntory Pharma Co Ltd, Daiichi Technos Co Ltd, Kansai Daiichi Service Co Ltd
For more information visit http://www.researchandmarkets.com/reports/c26623.
Source: Business Wire
Related Articles
- Jerini Ophthalmic and PR Pharmaceuticals Sign Collaboration Agreement to Develop Sustained-Release Formulations for the Treatment of Eye Diseases
- ''Vietnam: Telecommunication'' Covers The Overview, Statistics, Development And Segmentation Of Telecommunication Industry In Vietnam
- 'Vietnam: Mining' Covers the Global and Vietnam Mining Industry Overview, the Development Planning and the Socio-Economic Development Strategy
- Diplomats Member Signs Unique Advertising Deal With Philadelphia-Based Focus Entertainment
- Acura Pharmaceuticals, Inc. Updates OxyADF Tablets Development Program and Results of Study AP-ADF-102
- Immunicon and Eisai, Co. Ltd. Enter Research Agreement for Biomarker Development With Circulating Tumor Cells
- Teva Pharmaceutical Industries Ltd. And Protalix Biotherapeutics Ltd. Announce a Collaboration Agreement for the Development of Two Biopharmaceuticals, Based on Protalix's Recombinant Plant Cell Expression Technology
- Lev Pharmaceuticals' Drug Candidate for Hereditary Angioedema Focus of Broadcast News Story
- PerkinElmer to Sell Off Units in Deals Worth $400m to Focus on Life Sciences
- Lucent lands contract to help Iraq modernize Deal includes technology developed here
User Comments (0)


RSS Feeds